CEO of SCYNEXIS Buys Over 50% of Shares Amid Orphan‑Drug Milestone AnnouncementCEO insider buying of SCYNEXIS shares signals confidence in SCY‑770 orphan‑drug pipeline and future milestone payments.SCYNEXIS Inc Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 02/04/2026, 14:17 3 minutes to read
